이미 소장하고 있다면 판매해 보세요.
|
List of Contributors. Editor Bio. Chapter 1: Neurological Disorders and their Impact. Chapter 2: Physiological Barriers Of Targeting The Diseased Brain. Chapter 3: Poly (ADP-ribose) polymerase (PARP) as a Novel Therapeutic Target for Developing Treatments Against Neurological and Neurodegenerative Conditions. Chapter 4: Targeting Microglia for the Treatment of the Diseased brain. Chapter 5: Novel Nanoparticles as Drug Delivery Systems to the Brain. Chapter 6: Exosomes for Drug Delivery to the Brain. Chapter 7: Targeting The Brain With Monoclonal Antibodies. Chapter 8: In vitro Evaluations of Drug Delivery to the Brain. Chapter 9: In vivo Evaluations of Drug Delivery to the Brain. Chapter 10: Introduction to Hematological & Immunological Safey in Brain Drug Delivery. Chapter 11: Cytotoxic Evaluations of the Drug Delivery Systems to the Brain. Chapter 12: Personalised Therapies for Rare Neurological Disorders. Chapter 13: Industrial Aspects to be considered for drug delivery for brain. Chapter 14: Regulatory Aspects to be considered in the Development of Drug Delivery Systems to the Brain. Index |